Visualization of Candida albicans in the Murine Gastrointestinal Tract Using Fluorescent In Situ Hybridization
November 5th, 2019
17.8K views
The purpose of this protocol is to visualize Candida albicans cell shape and localization in the mammalian gastrointestinal tract.
Overview
This protocol visualizes the cell shape and localization of Candida albicans in the mammalian gastrointestinal tract. It provides insights into the fungus's interactions within its natural environment.
Key Study Components
Area of Science
- Microbiology
- Gastroenterology
- Pathogen Biology
Background
- Candida albicans is a common fungus in the gut.
- Understanding its morphology and localization is crucial for studying gut health.
- Interactions with the microbiota may influence diseases like inflammatory bowel disease.
- Traditional laboratory models may not accurately reflect gut conditions.
Purpose of Study
- To visualize Candida albicans in its natural gastrointestinal environment.
- To identify its morphological forms and localization within the gut.
- To develop a technique for diagnosing specific microorganisms in biopsy specimens.
Methods Used
- Gavage technique for inoculating animals.
- Dissection of gastrointestinal segments for tissue sampling.
- Histological processing of tissue samples.
- Use of hybridization probes for visualization of Candida.
Main Results
- Successful visualization of Candida albicans in the gut.
- Identification of its localization and morphological diversity.
- Insights into its interactions with host structures and microbiota.
- Potential applications in diagnosing gut-related diseases.
Conclusions
- This protocol enhances understanding of Candida biology in the gastrointestinal tract.
- It provides a valuable tool for studying gut microbiota interactions.
- Future research may explore its implications in gastrointestinal diseases.
Frequently Asked Questions
What is the significance of studying Candida albicans in the gut?
Studying Candida albicans helps understand its role in gut health and disease.
How does the gavage technique work?
Gavage involves delivering a specific volume of inoculum directly into the animal's stomach.
What are the main challenges in this protocol?
Challenges include proper animal handling and ensuring accurate tissue sampling.
What is the role of the microbiota in this study?
The microbiota may influence the behavior and localization of Candida albicans in the gut.
How can this technique be applied in clinical settings?
It can potentially diagnose specific microorganisms in biopsy specimens from patients.
What are the implications of this research?
This research may lead to better understanding and treatment of gut-related diseases.
Executive Industry Relevance
Visualizing fungal morphology and spatial distribution in complex host environments supports target validation in antifungal discovery. This method enables mechanistic de-risking by linking Candida albicans phenotypes to gut localization and microbiota interactions. It provides predictive confidence for evaluating therapeutic candidates in preclinical models of gastrointestinal colonization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by resolving Candida albicans localization and morphological states in vivo.
- Operational Value: Enables functional target validation through direct observation of fungus-host spatial relationships.
- Predictive Value: Supports portfolio triage by correlating fungal morphology with colonization stability and disease association.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for antifungal compound screening by preserving native gut architecture.
- Operational Value: Standardizes tissue preparation and hybridization protocols for reproducible quantitative imaging.
- Scalability: Facilitates platform reuse across model systems to assess compound effects on fungal localization and morphology.
Translational & Preclinical Research
- Scientific Value: Aligns with disease-relevant systems by modeling Candida albicans in murine GI tracts linked to inflammatory bowel disease.
- Operational Value: Ensures continuity from discovery through preclinical validation via consistent visualization of fungal dynamics.
- Risk Mitigation: Supports risk-adjusted advancement decisions by characterizing morphological transitions that influence pathogenicity.
Pipeline & Workflow Integration
The method integrates into discovery workflows by enabling hypothesis testing, assay readiness, and quantitative phenotypic analysis prior to lead optimization.
- Discovery Biology: Supports hypothesis testing and pathway clarification by visualizing fungal localization relative to host structures.
- Screening: Delivers assay readiness through standardized fixation and hybridization that preserve luminal microbiota and mucus layers.
- Analytics: Generates quantitative morphological and spatial readouts to compare conditions across mutant strains or treatment groups.
- Translational Research: Connects to preclinical continuity by modeling human-relevant GI colonization and inflammation-associated phenotypes.
- Enterprise Reuse: Establishes a reusable imaging platform for longitudinal studies of fungal persistence and therapeutic response.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in fungal-host interactions.
- Operational Value: Enhances reproducibility and scalability through standardized tissue processing and probe-based detection.
- Strategic Value: Improves go/no-go decisions by providing spatial and morphological data linked to colonization outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization by identifying compounds that alter fungal localization or virulence-associated forms.
Implementation Considerations
- Requires expertise in animal handling, gavage technique, and gastrointestinal dissection to maintain tissue integrity.
- Dependent on histological infrastructure including fixation, paraffin embedding, and fluorescence microscopy capabilities.
- Necessitates cross-team standardization of probe design, hybridization conditions, and washing protocols for consistent results.
- Involves adaptation considerations when applying to different model systems or fungal strains with variable morphology.
- Limited by the need for specialized training in gavage and dissection to avoid artifacts that compromise spatial accuracy.
Biopharma FAQs
Why does fluorescent in situ hybridization matter for target validation?
Fluorescent in situ hybridization enables direct visualization of Candida albicans localization and morphology in host tissues, providing critical spatial and phenotypic data for evaluating antifungal targets. This approach supports mechanistic de-risking by linking target engagement to observed changes in fungal behavior within the gastrointestinal niche.
How does gavage technique isolation fit the discovery pipeline?
The gavage technique delivers a controlled inoculum to establish standardized gastrointestinal colonization, enabling reproducible modeling of host-fungus interactions. This procedural control ensures that downstream phenotypic assessments reflect true biological responses rather than variability in inoculation.
What quantitative measurements does fungal rRNA probe staining enable?
Fungal rRNA probe staining generates quantitative fluorescence signals that allow measurement of Candida albicans abundance, morphological distribution, and spatial association with host structures. These metrics support comparative analysis across experimental conditions to assess therapeutic impact on colonization dynamics.
Why do replication requirements matter for cross-functional collaboration?
Replication requirements ensure that visualization results are consistent across animals and experimental runs, which is essential for building confidence in target validation data. Standardized protocols facilitate reliable data sharing between discovery, preclinical, and translational teams working on antifungal development.
What statistical analysis capabilities are required before implementation?
Implementation requires statistical capabilities to compare fungal localization, morphology, and signal intensity across experimental groups, enabling objective assessment of therapeutic effects. These analyses support data-driven decisions on compound efficacy and mechanism of action in preclinical models.
Chapters in this video
0:04
Title
3:30
Preparation of GI Tissues for Histology
5:50
FISH Staining in GI Tract Tissues
9:17
Conclusion
1:28
Gastrointestinal Colonization of Mice with C. albicans Using Oral Gavage
8:22
Results: FISH-stained C. albicans In Vitro and in Different Gut Compartments
